Shannon Tokheim, Associate Editor at MarketBeat Articles Reviewed by Shannon Tokheim - Page 104July 10, 2024 9:03 AM ETAI Partnership Boosts This Top Tech Stock: Ready for More Gains?Chris MarkochPalantir stock is one of the best-performing stocks in 2024, and investors wonder if it has room to run higher; recent developments suggest it mayNYSE:PLTRNASDAQ:NVDANYSE:ORCLRead AI Partnership Boosts This Top Tech Stock: Ready for More Gains?July 10, 2024 8:29 AM ETThis Tech Stock Can Set a Multiyear High with AI-Powered GrowthThomas HughesSGH is emerging as an AI winner due to demand for its memory, intelligent platforms, and LED technology. Analysts rate the stock as a buy and lead it higher.NASDAQ:SGHRead This Tech Stock Can Set a Multiyear High with AI-Powered GrowthJuly 10, 2024 7:20 AM ETMajor Acquisition: Aerospace Powerhouse Buys Its Key SupplierLeo MillerBoeing recently announced it will acquire one of its key suppliers Spirit AeroSystems. Boeing hopes to rectify quality control issues in its supply chain.NYSE:BANYSE:SPREPA:AIRRead Major Acquisition: Aerospace Powerhouse Buys Its Key SupplierJuly 10, 2024 6:45 AM ETOne of the Top Food Stocks to Own: Delivering Outstanding GrowthSam QuirkeWith Domino's history of setting high after high as it rallies, this is one to be watching closely and getting excited about.NYSE:DPZNASDAQ:PZZARead One of the Top Food Stocks to Own: Delivering Outstanding GrowthJuly 10, 2024 5:16 AM ETTop 2 Cybersecurity Stocks Booming in an Age of Rising ThreatsJeffrey Neal JohnsonCybersecurity stocks offer a promising investment opportunity as businesses navigate a rapidly evolving and increasingly perilous digital landscape. NASDAQ:CRWDNASDAQ:ZSRead Top 2 Cybersecurity Stocks Booming in an Age of Rising ThreatsJuly 10, 2024 5:14 AM ETTeva Pharmaceuticals Stock: Unlock Value in This Generic Drug GemJea YuDrug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024NYSE:TEVANYSE:ABBVNYSE:MRKRead Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug GemJuly 10, 2024 5:12 AM ETUncover Why This Pharma Stock Jumped 400% on Study UpdateRyan HassonShares of Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, surged almost 400% today after announcing positive data.NASDAQ:SNGXRead Uncover Why This Pharma Stock Jumped 400% on Study UpdateJuly 10, 2024 5:11 AM ETJumia Technologies Stock Jumps: Analyst Update Drives 30% GainThomas HughesJumia Technology is initiated at Buy by Benchmark, sending its shares up by 30% and more gains are coming. This company is well-positioned to capture eCommerceNASDAQ:AMZNNYSE:JMIARead Jumia Technologies Stock Jumps: Analyst Update Drives 30% GainJuly 10, 2024 5:06 AM ETHot Summer Picks: Best Dividend Stocks to Invest In Right NowJeffrey Neal JohnsonUnlock steady income and potential growth by aligning your portfolio with seasonal trends through dividend-paying companies. NYSE:HDNASDAQ:POOLNASDAQ:TSCORead Hot Summer Picks: Best Dividend Stocks to Invest In Right NowJuly 10, 2024 5:05 AM ETTap Into Molson Coors Stock: A Top Beverage Value PlayJea YuMolson Coors Beverage Co. (NYSE: TAP) stock recently fell to 52-week lows as it struggled to maintain any bounce attempts. The negative trajectory took over itsNYSE:TAPNYSE:BUDNYSE:STZRead Tap Into Molson Coors Stock: A Top Beverage Value PlayJuly 9, 2024 9:27 AM ET3 Insider-Buy Stocks to Add to Your Watchlist NowThomas HughesInsiders are buying these stocks that should be on your radar, but only two are set up to rebound and move higher today; the third may move lower first.NYSE:LEGNASDAQ:BCRXNYSE:PBFRead 3 Insider-Buy Stocks to Add to Your Watchlist NowJuly 9, 2024 8:26 AM ETCommvault Stock: AI Cybersecurity Giant Ready to Double AgainThomas HughesCommvault's shift to the SaaS model is gaining traction and driving growth for this AI-powered data protection service. Analysts and institutions are buying. NASDAQ:CVLTRead Commvault Stock: AI Cybersecurity Giant Ready to Double AgainJuly 9, 2024 8:02 AM ETIntuit Stock Ready to Soar: RBC Sees Big Upside with GenAILeo MillerRBC Capital recently initiated coverage on Intuit. Their $760 price target implies a 15% upside. RBC believes Intuit can us gen-AI to drive significant value.NASDAQ:INTURead Intuit Stock Ready to Soar: RBC Sees Big Upside with GenAIJuly 9, 2024 7:45 AM ETPDD Holdings is a Screaming Buy: Hypergrowth Stock at a DiscountJea YuPDD Holdings Inc. (NASDAQ: PDD) is a Chinese e-commerce company mainly operating 2 popular online businesses. The core business is the social commerce company NASDAQ:PDDNYSE:BABANASDAQ:JDRead PDD Holdings is a Screaming Buy: Hypergrowth Stock at a DiscountJuly 9, 2024 5:19 AM ETGreenbrier Companies Stock Enters Buy Zone – Opportunity KnocksThomas HughesThe Greenbrier Companies struggled in Q3 but sustained its fortress balance sheet and guided for growth to resume soon. The dividend is safe. NYSE:GBXRead Greenbrier Companies Stock Enters Buy Zone – Opportunity KnocksJuly 9, 2024 5:18 AM ETEli Lilly Stock Leads in GLP-1 Race with its Triple Agonist DrugJea YuGlobal pharmaceutical company Eli Lilly & Co. (NYSE: LLY) has been in a GLP-1 arms race with its FDA-approved therapies Mounjaro and Zepbound. It's been NYSE:LLYNYSE:NVONASDAQ:ALTRead Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist DrugJuly 9, 2024 5:15 AM ETGet Ready: 3 High Short Interest Stocks Poised for a Melt-UpGabriel Osorio-MazilliThree high short interest stocks are now a potential short squeeze set up for investors to take advantage of. Analysts see double-digit upside in each NASDAQ:NVDANYSE:GMENYSE:CAVARead Get Ready: 3 High Short Interest Stocks Poised for a Melt-UpJuly 9, 2024 5:10 AM ETInside Scoop: Bank of America Raised Potlatch Stock Price TargetGabriel Osorio-MazilliPotlatch stock is now a much better deal than even Nvidia, markets like it and institutions have bought it to drive away short sellers in its 50%+ upsideNYSE:WYNYSE:WFGNASDAQ:NVDARead Inside Scoop: Bank of America Raised Potlatch Stock Price TargetJuly 9, 2024 5:08 AM ETAI Boom: Micron Stock Dip vs. NVIDIA's Upgrade – Which Is Better?Gabriel Osorio-MazilliMicron stock is showing investors just how it can deliver much more upside than its peers in the semiconductor space, backed by analyst projections and targetsNASDAQ:MUNASDAQ:NVDANYSE:TSMRead AI Boom: Micron Stock Dip vs. NVIDIA's Upgrade – Which Is Better?July 9, 2024 5:05 AM ETUiPath’s GenAI Expansion Could Skyrocket Its Value - Rally Ahead?Jea YuUiPath Inc. (NASDAQ: PATH) is the leader in robotic process automation and business process automation. The company has been involved with AI for yearsNYSE:PATHNASDAQ:PEGANYSE:CRMRead UiPath’s GenAI Expansion Could Skyrocket Its Value - Rally Ahead?July 9, 2024 5:00 AM ETHot Stock Splits Ahead: 3 Major Ones to Put on Your WatchlistThomas HughesStock splits don't alter the fundamental drivers of a stock's price, but only good companies have a reason or need to do it.NASDAQ:AVGONYSE:WMTNASDAQ:NVDARead Hot Stock Splits Ahead: 3 Major Ones to Put on Your WatchlistJuly 8, 2024 9:57 AM ETDon’t Miss These Stock Picks for the Lumber Price SurgeGabriel Osorio-MazilliWest Fraser Timber Co. is now the best choice for investors to get over 60% upside in the new housing demand cycle, standing above peers in all factorsNYSE:OXYNYSE:WYNYSE:LENRead Don’t Miss These Stock Picks for the Lumber Price SurgeJuly 8, 2024 9:38 AM ETNVIDIA Stock Defies Skeptics, Earns Analyst UpgradeJeffrey Neal JohnsonAnalyst upgrades highlight NVIDIA's robust financials and AI market leadership, fueling investor optimism despite recent insider selling. NASDAQ:NVDARead NVIDIA Stock Defies Skeptics, Earns Analyst UpgradeJuly 8, 2024 9:06 AM ETTop Oil Stocks Primed to Surge Ahead of Buffett's Occidental MoveGabriel Osorio-MazilliTwo oil stocks are making headways into beating Occidental Petroleum even after being chosen by Warren Buffett himself, analysts agree on EPS and price targetsNASDAQ:NVDANYSE:WMBNYSE:XPRORead Top Oil Stocks Primed to Surge Ahead of Buffett's Occidental Move Page 104 of 119 « Most Recent‹ More Recent101102103104105106107 Earlier › Earliest » Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
